Welcome to the Life Science Hub, a new integrated offer for the life sciences industry, delivered collaboratively by experts from the NHS’s four Commissioning Support Units (CSUs).
On this page:
The CSU collaborative: Your NHS partner of choice
We bring deep insight into NHS systems, pathways, and decision-making, with Board-level leadership and policy-to-practice experience. Now united under one Managing Director, the four CSUs offer national reach and integrated expertise to support NHS and Life Sciences partners.
Our data, health economics, and transformation capabilities deliver actionable intelligence for market access and strategic goals. We combine our technical abilities with a deep understanding of the typical challenges the Life Sciences industry experience in terms of adoption of recommended treatments across care pathways. Our team enable the NHS to work more effectively with industry through a clear value improvement lens.
As a not-for-profit NHS organisation, your investment stays in the system—creating social value and enabling innovation.
Our offer
The Hub aims to offer expert assistance, specialised skills, and knowledge from experienced NHS staff to the life science sector. Its goal is to help the industry understand the NHS landscape and enhance the positive effects of their work on patient populations.
We strive to assist the life sciences sector in engaging effectively with the NHS to enhance the impact of their innovations. Our consultancy services are customised for evidence generation, market access, pathway alignment, and operational deployment, supporting both new and established companies in NHS engagement and sustainable growth.
Our Services
Whether you’re a start-up looking to understand how you can start working with the NHS, or you have an established offer that you want to better understand the impact of, we offer a range of bespoke services to suit your needs.
Acceleration and adoption
We support the life sciences industry to bring new treatments and technologies to market by aligning them with NHS priorities and pathways. Our consultancy provides support across evidence generation, market access, and implementation to accelerate adoption and impact.
- Market Access Strategies and NHS Readiness: landscape mapping, route to market strategies, HTA support, stakeholder engagement and planning.
- Evidence Generation and Evaluation: Real World Evidence, health economics and outcomes research, clinical evaluation and feasibility, service impact modelling.
- Integration and Implementation: operating model deployment options, pathway readiness, planning and facilitation, procurement and business case development
- Data access and Insights: Access to data assets, data analytics and visualisation, benchmarking.
- Co-development and Strategic Partnerships: Joint grant applications, strategic partnership modelling
Maximising impact and optimisation
We support the life sciences industry in optimising existing treatments by using NHS data, clinical insights, and pathway expertise. Our consultancy enhances real-world effectiveness, improves service efficiency, and strengthens value for long-term adoption and growth.
- Performance Analysis and Impact Evaluation: Real World evidence studies, comparative effectiveness research, cost effectiveness and patient outcome analysis.
- Pathway Optimisation and Integration Support: Care pathway mapping and redesign, barriers and enablers analysis, dissemination support
- Service Delivery Optimisation: Medicine optimisation, workflow analysis, operational redesign, digital enablement
- Post market surveillance and safety monitoring: Risk mitigation and regulatory support
Strategic advisory support
We partner with the life sciences industry and help them navigate and succeed in the NHS by offering strategic access support, operational deployment expertise, and real-world insights to drive adoption and scale.
- Strategic Market Access and NHS Navigation: System navigations, policy and landscape intelligence, market access planning.
- Planning and Operationalisation: Implementation plans, readiness assessments, strategies, scale up.
- Stakeholder engagement and Communications: Stakeholder mapping, co-developed engagement strategies, advisory board facilitation
- Data strategy and NHS Insights: NHS data opportunity mapping, predictive modelling support, real world data insight analysis
- Strategic Advisory Support: Innovation strategy alignment, partnership and collaboration development
Our offer for the NHS
The Life Science Hub offers a bridge between industry and the NHS. As part of the NHS, we understand the challenges which decision makers and commissioners face and our expert team can help you navigate them.
Our services for the NHS include:
- Evidence generation – helping you understand the impact that new technologies will have in your system and making a case for their adoption
- Pathway optimisation – exploring treatment and prevention pathways and finding the best solutions to optimise budgets for improved population health
- Programme support – ensuring innovations are adopted swiftly, smoothly and sustainably
Our work
Supporting the life sciences industry to embed new technologies that help the prevention of atrial fibrillation strokes
Experts within our Life Science Hub were sponsored by the BMS-Pfizer Alliance to create an Atrial Fibrillation digital toolkit, allowing NHS commissioners to identify impactful treatments and interventions in their area.
Andi Orlowski and Wayne Smith, of the Health Economics Unit, used published data of primary care performance, QOF targets and prevalence estimates to identify optimal goals for AF management, and helped to create realistic business plans for treating the condition. They created a digital tool which CCGs could use with their own local data, to identify gaps in services and calculate their potential costs.
As part of an online AF Toolkit, the work:
- prevented an estimated 500 strokes
- saved a potential $3m per year
- secured £300,000 investment from industry
More than 25 new partnerships were established to support the AF stroke-prevention programme.
Supporting the life sciences sector to deliver efficiencies through economic modelling for Peripheral Arterial Disease (PAD)
Experts within our Life Science Hub supported Abbott Laboratories to quantify the impact of reducing initial amputations in Peripheral Arterial Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI) patients. This economic modelling was designed to demonstrate the potential impacts on NHS resource use and budgets across England and Wales.
Our business intelligence and analytics specialists developed an interactive model utilising data from the Kent Integrated Dataset and the National Vascular Registry. This model enabled instant, customisable cost analyses for individual centres, Integrated Care Systems (ICSs), or nationwide assessments.
The reduced-amputation pathway successfully demonstrated the potential net cost savings. The findings were robust under sensitivity tests, ensuring reliability and validity. The client praised the model’s clarity and the balance of the technical report, highlighting its effectiveness in addressing the challenge.
Supporting the life sciences sector with Specialised Commissioning Training
In April 2024, NHS England delegated 59 specialised services to Integrated Care Boards (ICBs). This transition required @Boehringer Ingelheim to quickly acquire practical knowledge of service specifications, contract frameworks, and funding flows to ensure seamless operations.
Experts from the Life Science Hub collaborated with senior stakeholders within Boehringer Ingelheim to design and deliver four specialised 50-minute training modules. These modules covered policy, finance, governance, and specialised medicines, and were tailored to specific roles within the organisation. The training was supported by an evergreen slide library, providing ongoing access to updated information.
As a result of this training initiative, Boehringer Ingelheim employees now navigate the complexities of delegated commissioning with confidence. The comprehensive training modules enable swift onboarding of new staff, reducing the time required to integrate them into the system. Additionally, the on-demand toolkit ensures that staff maintain NHS-aligned expertise, allowing teams to stay updated with the latest developments and best practice.
Our people
We have a team of experienced experts across a range of disciplines, who are committed to finding the best solutions to improve health outcomes across the NHS.
Clinical
Tina Bramley, Associate Director, NHS Arden and Greater East Midlands CSU
Dr Olu Akinremi, Value Implementation Lead, NHS Arden and Greater East Midlands CSU
Jonathan Horgan, Director of Pharmacy Services, NHS Midlands and Lancashire Commissioning Support Unit
Helen Pearson, Senior Clinical Pharmacist, NHS Midlands and Lancashire Commissioning Support Unit
Ian Morris, Senior Clinical Services Manager
Alex Evans
Consultancy
Rebecca Dennett, Programme Lead for Strategy and Partnering (Life Sciences), NHS Arden and Greater East Midlands CSU
Ayesha Janjua, Associate Director – ICS Development, NHS Arden and Greater East Midlands CSU
Rose Taylor, Exec Director Health and Care Transformation, NHS Arden and Greater East Midlands CSU
Gary Graham, Director Strategy and Development, Health and Care Transformation, NHS Arden and Greater East Midlands CSU
Denis Gizzi
Rachel Helmn, Head of Consultancy – Growth Lead, North of England Commissioning Support
Analytics/Economics
Helen Duckworth, Director of Business Intelligence Transformation, NHS Arden and Greater East Midlands CSU
Jürgen Mitsch, Head of Data Science, NHS Arden and Greater East Midlands CSU
Andi Orlowski, Director, Health Economics Unit
David Sgorbati, Chief Analyst, Health Economics Unit
Ben Murch
Public health specialists
Claire Cheong-Leen, Associate Director SPH & Clinical Insight, NHS Arden and Greater East Midlands CSU
Richard Harrety, Senior Business Manager, North of England Commissioning Support
Gill D’eath (PHM)
Change management
Duncan Harper, Head of Midlands Region – Consultancy
Contact us
If you would like to know more about our work and how we can help you contact us at agem.strategicvaluepartnership@nhs.net.